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ABSTRACT
The objectives of this study were to determine what effects iodixanol would have on total and
progressive motility, plasma membrane integrity (viability), acrosome integrity and DNA structure
when present during cryopreservation of equine spermatozoa,. We hypothesized that the addition
of iodixanol would improve post-thaw values for measured parameters. Ejaculates from six stallions
were collected, centrifuged at 900 x g for ten minutes to remove supernatant, and suspended to
200 x 106 cells/ml with 0%, 2.5% and 5% iodixanol in an egg-yolk based extender and

cryopreserved. Before and after cryopreservation sperm motility was assessed by computer
assisted semen analysis, and samples were stained with SYBR-14/propidium iodide (PI) for viability,
with PI/fluorescent isothiocynate-PNA (Arachis Hypogaea) for acrosome integrity and assessed by
flow cytometry. Sperm DNA was evaluated using the sperm chromatin structure assay test and
assessed by flow cytometry. The mean (± S.E.) percentage pre- and post-thaw total motility,

progressive motility, viability, acrosome reactivity, COMPαt and MEANαt were analyzed using
Shapiro-Wilk test to evaluate if data followed a normal distribution. When results followed a
normal distribution an ANOVA was performed and where a significant interaction of treatment
was observed (p=0.05), a Tukey-Kramer post-hoc test was applied. If results did not follow a
normal distribution, a binomial logistical regression was performed. The 5% post-thaw
treatment group showed increased viability and decreased DNA damage (p<0.001). Although
the 0% group showed greater total and progressive motility than the 2.5% group, it was not
greater than the 5% group. The 5% post-thaw treatment group had significantly more (p<0.001)
non-reacted and damaged acrosomes than both the 0% and 2.5% groups. These findings
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suggest that the presence of iodixanol during cryopreservation may have a beneficial effect by
protecting plasma membrane and sperm DNA, but the exact mechanism of action is unknown.

ix

CHAPTER 1
INTRODUCTION

The goal of spermatozoal cryopreservation is the ability to preserve sperm with no
negative effects of processing; and the sperm would perform, when thawed, just as well as it
would have if it was never frozen. The first reported pregnancy using cryopreserved stallion
epididymal spermatozoa was in 1957, using epididymal sperm, used whole milk with 10%
glycerol as a freezing extender (Barker & Gandier, 1957). In this study, seven mares were
artificially inseminated and one subsequently foaled: a 14.29% pregnancy rate. Since then, the
expected pregnancy rate of frozen semen now ranges from 38% to 73% (Metcalf, 1995, Nielsen
et al., 2008), with a mean of 40% to 45% (Vidament, 2005). This is not a large improvement for
such a long time span, when compared to equine oocyte collection and transfer, which had its
first reported pregnancy to term in 1988 by McKinnon (1/15, 7% foaling rate). By 1995 a
pregnancy to term rate of up to 95% has been reported (Carnevale and Ginther, 1998).
This slow advancement in the technique of spermatozoal cryopreservation is surprising,
since breeding with frozen semen is now a routine insemination technique practiced worldwide. This may be due to underfunding, as many breed registries prohibit its use, and also to
the low pregnancy rates obtained. However by 1985, up to 32,000 mares were bred in three
provinces in China, with a pregnancy rate of 68% (Amann & Pickett, 1987). In recent years, large
breed registries, particularly the American Quarter, American Paint Horse and the Arabian,
have allowed the use of frozen semen based on its advantages including not requiring the
shipping of mares to breeding farms; the coordination of chilled semen request in anticipation
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of ovulation; the long-term storage of semen of competing, injured or dead stallions; and the
ability to transport semen internationally.
In stallions, sperm motion characteristics are lowered after storage with high
concentrations of seminal plasma, and the lowering of seminal plasma concentrations is
beneficial to motility (Jasko et al., 1991). An important step in cryopreservation is reducing
seminal plasma concentration, and is performed by the centrifugation of spermatozoa and the
subsequent removal of the seminal plasma supernatant. Industry standard centrifugation
forces are typically 400-600 x g. A sperm cushion can be added to allow increased
centrifugation forces and to obtain increased spermatozoal recovery rates. Reported recovery
rates with an iodixanol based cushion medium ranged from 81% to 107% (Ecot et al., 2005)
after centrifugation for 20 minutes at 1000 x g. The complete recovery of the entire iodixanol
cushion is a difficult procedure; the cushion media must be removed without disrupting or
losing any of the soft pellet. As a result, erring on the side of caution, the cushion is frequently
incompletely removed and iodixanol residues are left remaining with the pellet. Sargusty et al.,
(2009) examined what the effects of these residues could be if iodixanol was added to a bovine
freezing extender (Andromed®). The presence of 1.25%, 2.5% and 5% iodixanol (Optiprep™,
v/v) during freezing was associated with improved semen longevity and acrosomal viability. To
date no similar study has been performed with equine spermatozoa.
The objective of this study was to evaluate the effect of 0%, 2.5% and 5% iodixanol
(Optiprep™ (v/v)), in an egg yolk and glycerol based freezing extender (EZ Freezin LE, Animal
Reproduction Services, Chino, CA), on equine spermatozoal total and progressive motility,
viability, acrosomal integrity and chromatin integrity.
2

CHAPTER 2
LITERATURE REVIEW

2.1. Stallion Sperm Structure
The equine spermatozoon can be divided into a head, neck, middle piece, principal
piece and end piece, and is completely surrounded by a continuous and fluid plasma
membrane. The spermatozoal head contains the nucleus, acrosome and cytoplasm. The
nucleus occupies the majority of the spermatozoal head space, and contains highly condensed
chromatin. This tight condensation of nuclear material is due to establishment of intra- and
inter-molecular disulfide linkages that result in compaction and stabilization of the DNA (Varner
and Johnson, 2007). These bonds are formed during passage of the spermatozoa through the
epididymis, and are believed to occur as the compacted state offers protection during
spermatozoal movement prior to fertilization. The nucleus is surrounded by a nuclear envelope,
which is a double membrane separating the nucleus from the surrounding cytoplasm.
The acrosome is an exocytotic organelle, covering the rostral two-thirds of the nucleus.
It is a membrane bound structure, with connected inner and outer acrosomal membranes,
enclosing an acrosomal matrix composed of hydrolytic enzymes (hyaluronidase,
proacrosin/acrosin and lipases) (Varner and Johnson, 2007). During the acrosome reaction, the
outer acrosomal membrane and the spermatozoal plasma membrane fuse, resulting in
exocytotic release of the enzymes and exposure of the binding receptors. The remainder of the
spermatozoal head is composed of cytoplasm, containing few organelles and mostly contains
cytoskeletal proteins that are important for spermatozoal form and function (e.g. anchoring the
acrosome to the underlying nuclear envelope; Varner and Johnson, 2007).
3

The neck and tail (composed of the middle piece, principal piece and end piece)
comprise the rest of the sperm. The neck is the connecting piece between the head and the
middle piece and consists of the capitulum, segmented columns and the proximal and distal
centrioles (Varner and Johnson, 2007). The proximal centriole remains present in the mature
spermatozoa and is the site where the tail beat is initiated. The distal centriole develops into
the axoneme during spermatozoal tail development. The middle piece contains numerous
mitochondria overlying the dense fibers and the axoneme. Mitochondria are helicoidally
arranged in a continuous double spiral, and produce ATP required for flagellar movement
(Varner and Johnson, 2007).
The principal piece is composed of the axoneme, which is continued from the middle
piece and terminates in the caudal principal piece, and the fibrous sheath. The axoneme is a
cylindrical array of nine doublet microtubules that surround two singlet microtubules (termed
the central pair) connected by regularly spaced bridges, thus forming the characteristic ‘9+2’
configuration. The outer fibrous sheath provides structural support and flexibility to the
flagellum (Varner and Johnson, 2007).
The equine spermatozoal plasma membrane is the outer most component and
completely encompasses the entire cell and is composed of lipids and proteins (Flesch and
Gadalla, 2000), and how spermatozoa respond to a decrease in environmental temperature is a
direct measure of how the lipid and protein components of the membrane alter in response to
decreasing temperatures. As temperature decreases, sperm membrane destabilization occurs
when the membrane undergoes a phase transition from the fluid phase to the gel phase. Due
to the loss of most cell organelles and DNA transcription ability during spermatogenesis,
4

spermatozoa lack vesicular transport. As a result the plasma membrane is a stable and inert
structure, and plasma membrane components (protein, phospholipids and cholesterol) cannot
be synthesized de novo (Flesch and Gadella, 2000). The plasma membrane is composed of
three zones: lipid bilayer, phospholipid-water interface, and glycocalyx (Amann and Graham,
2010).
The lipid bilayer is composed of polar phospholipids, with hydrophobic fatty acyl chains
directed internally and the hydrophilic, charged polar head groups directed externally. The
plasma membrane lipids mostly consist of phospholipids and cholesterol; other lipids present
include neutral lipids and glycolipids; however, phospholipids comprise up to 70% of all lipids
present (Flesch and Gadella, 2000). Also present in the plasma membrane are proteins that are
classified as either integral or peripheral proteins. Proteins account for up to 50% of the plasma
membrane weight (Amann and Pickett, 1987). The integral proteins serve as pores or channels
through the membranes or as receptors for ligands. The peripheral proteins are attached to the
plasma membrane by electrostatic forces. Many of the integral and peripheral proteins contain
carbohydrate side chains and extend some distance from the lipid bilayer (Amann and Pickett,
1987). The carbohydrate side chains have a net negative charge and attract and loosely bind
other proteins or glycoproteins, resulting in the outer surface of the plasma membrane having a
transient covering of material that is dependent on its surrounding environment. The
cholesterol to phospholipid molar ratio in the plasma membrane of stallion spermatozoa is
0.36, which is midway between the values for boar (0.26) and bull (0.45) spermatozoa (Parks
and Lynch, 1992). The plasma membrane is in a fluid state at body temperature, allowing
phospholipids to move freely, resulting in differences in phospholipid distribution throughout
5

the membrane. The ratio of cholesterol to phospholipids with polyunsaturated acyl side chains
will determine the fluidity of the membrane, with higher levels of cholesterol associated with
better membrane decreased fluidity but better stability during cooling (Amann and Pickett,
1987).
2.2. Stallion Sperm Cryopreservation
It is estimated that 20% of stallions produce semen that freezes well, 60% freeze
acceptably and 20% freeze badly (Vidament et al., 1997). When compared to the bull, stallions
are considered poor freezers, and the reason for this is not completely understood. Bulls have
been selected by the AI industry for many years based on the ability of their spermatozoa to
withstand the stress of standard cryopreservation protocols; no such selection process exists
for stallions (Loomis & Graham, 2008). Some reasons postulated to explain the poor freezability
of equine spermatozoa include the unique cell size and shape of equine spermatozoa, the
osmotic tolerance of sperm, the chemical composition of sperm, and the selection of stallions
based on athletic traits and not reproductive parameters (Amann & Pickett 1987, Squires 2005,
Loomis & Graham 2008).
There is no single standardized equine semen cryopreservation protocol. Samper and
Morris (1998) surveyed 21 world-wide laboratories that were involved in the freezing of semen
for commercial purposes. Their survey included many questions covering all aspects of
cryopreservation, including; the number of ejaculates collected to deplete extra-gonadal
reserves prior to the first freeze; the number of test-freeze extenders used; dilution ratio and
centrifugation protocol after collection; type of freezing extender used; type of antibiotics used;
equilibration of semen before cryopreservation; freezing concentration; freezing and thawing
6

procedure; post-thaw evaluation criteria; insemination recommendations; acceptable first cycle
pregnancy rate; and what the laboratory thought was the single most important factor when
freezing stallion spermatozoa. Each of the questions had more than one answer,
demonstrating that none of the researchers agreed on any single parameter. It has been
suggested a standard protocol should consist of two-step dilution procedure, in which the gelfree ejaculate is either diluted 1:1 or to 50 x 106 spermatozoa/ml with a centrifugation
extender, extended semen centrifuged for 10-15 minutes at 400-600g, the supernatant
(consisting of the centrifugation extender and seminal plasma)removed, re-extension of the
spermatozoal pellet with freezing extender to the desired freezing concentration, packaging
into 0.5-ml or 5-ml straws, cooling from room temperature to +5°C, freezing in either liquid
nitrogen vapor or in an automated freezing chamber, and storage in liquid nitrogen (Sieme
2010).
Similarly, there is no single standard equine freezing extender. Samper and Morris
(1998) reported four different freezing extenders that were being used by the surveyed
laboratories. Despite the difference in extenders being used, all laboratories combined a source
of energy (sugars), a source of lipoproteins to facilitate protection against rapid cooling (e.g.
milk, egg yolk, or a combination of both), antibiotics to inhibit bacterial growth, buffers to
balance pH, and a cryoprotectant. Cryoprotectants can be divided into permeable and
impermeable categories (Sieme et al., 2008). The permeable agents act as both a solvent and
solute and their presence will result in a higher concentration of water remaining unfrozen at
lower temperatures, which protects the cells by minimizing the time of exposure to critical salt
concentrations (Amann and Pickett, 1987, Sieme et al., 2008). Permeable cryoprotectants
7

include dimethyl sulfoxide, amides (methyl formamide and dimethyl formamide) and alcohols
(ethylene glycol and glycerol). Impermeable agents act solely as a solute (Loomis and Graham,
2008). Their mode of action includes protecting cells against rapid cooling, stabilizing the
plasma membrane, and by raising the percentage of unfrozen water at a given temperature
(Amann and Pickett, 1987, Sieme et al., 2008). Impermeable protectants include sugars
(lactose, mannose, raffinose), amino acids (glutamine and proline), proteins and lipids.
Glycerol is the most widely used permeating cryoprotectant used for the
cryopreservation of equine spermatozoa, and recommended concentrations are 2.5% to 3.5%,
although concentrations up to 10% glycerol have been reported (Samper and Morris, 1998).
Glycerol can exert both osmotic and chemical toxic effects. Spermatozoa are subjected to a
transient osmotic stress, as glycerol and extender ingredients equilibrates across the plasma
membrane, resulting in temporary spermatozoal dehydration and reduced cell volume. The
chemical toxic effects of glycerol exposure include protein denaturation, alteration of actin
interactions and induction of protein free membrane blisters (Alvaranga et al., 2005).
Alternatives to glycerol that possess a shorter period of equilibration have been investigated
(Squires et al., 2004). In this study a 0.55 M glycerol was compared to 0.3, 0.6 and 0.9 M methyl
formamide and dimethyl formamide, smaller amide molecules, and it was demonstrated that
0.6 and 0.9 M preparations of both methyl formamide and dimethyl formamide had a postthaw total motility statistically similar to the glycerol treatment (P<0.05). The results of this
study suggest that these amides are acceptable alternatives to glycerol.
Lipid based cryoprotectants, sourced from egg-yolk and milk, are a common component
of freezing extenders, although the exact mechanism of cryoprotective action of lipids during
8

cryopreservation is unclear; it is most likely caused by the low density lipoproteins (LDL) they
contain; proposed mechanisms of action include reversible binding to extracellular lipids in
stallion seminal plasma and fusion to the spermatozoal membrane (Ricker et al., 2006). In the
bull, seminal plasma proteins can cause cholesterol and phospholipid efflux from the
spermatozoal plasma membrane and the addition of low density lipoproteins resulted in a
phospholipid and cholesterol gain by the plasma membrane, which resulted in greater
protection of spermatozoa during cooling and cryopreservation (Bergeron et al., 2004). An
animal-free source of lipids is soybean lecithin. When used to freeze bull spermatozoa, a
soybean lecithin-based extender was shown to have a significantly higher post-thaw motility
and non-return rate when compared to an egg yolk-based freezing extender (Aires et al., 2003).
A soybean lecithin-based extender has recently become commercially available for the stallion
(Andromed-E™; Minitüb, Wisconsin).
2.3. Spermatozoal Response to Cooling
Rapid cooling of equine spermatozoa from 20 °C to 5 °C induces a partially
irreversible damage, which is characterized by abnormal motility, loss of motility, damage to
the plasma and acrosome membranes and reduced metabolism, and is aptly referred to as
cold-shock (Amann and Pickett, 1987). Watson et al., (1987) demonstrated that cold shock
damaged both the acrosomal and plasma membranes after rapidly lowering spermatozoal
temperature from 30 °C to 0 to 4 °C (Table 2.1). Ideally, the cooling rate of animal spermatozoa
should 0.5 to 1 °C/min (Barbas & Mascarenhas, 2009).
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Table 2.1 Percentage of spermatozoa with damaged head membranes after various degrees of
cold shock from 30 °C (Adapted from Watson et al., 1987).

Cold-shock temperature

Membrane categories
Intact Plasma & Acrosome
Membrane (%)
Damaged Plasma & Intact Acrosome
Membrane (%)
Damaged Plasma & Acrosome
Membrane (%)

30 °C

16 °C

8 °C

4 °C

0 °C

81

66

63

44

29

9

10

12

23

41

11

16

20

25

42

When spermatozoa are cooled, the lipids undergo a phase transition from a liquid state
into a gel or solid state, as cooling changes the shape of phospholipids. During membrane
transition there is straightening and lengthening of fatty acyl chains which allow phospholipids
to become tightly packed, and this process results in the aggregation or exclusion of proteins
(Quinn, 1985). Each phospholipid undergoes this phase transition at a different temperature
because there are many different acyl fatty chains present, with longer chains transitioning first
at a higher temperature, which occurs at 19 °C for stallion spermatozoa (Hammerstedt et al.,
1990). As the temperature drops further, more lipids undergo transition and further coalescing
occurs. The range of temperature over which phospholipid transition occurs is 20 or 30 °C, and
after the change to the gel or crystalline state phospholipids can no longer move in a random
fashion (Amann and Pickett, 1987). Coalescence of membrane phospholipids is a change from
the lamellar arrangement to a hexagonal-II form, which is a circular arrangement of
phospholipids, with the hydrophilic head groups facing out. This change in arrangement is due
to a change in shape of the fatty acyl chains due to cold exposure. Coalescence of membrane
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lipids causes increased membrane permeability, as hydrophilic channels are created between
the outer surface of the hexagonal-II forms and the surrounding phospholipid lamellar
arrangement (Amann and Pickett, 1987). Finally, upon reaching the lowest transitioning
temperature the entire membrane is in a gel state, and the membrane has lost its fluidity. The
formation of the hexagonal-II form is reversible, with return to the normal bi-lamellar
arrangement occurring upon warming; however this re-arrangement is an irreversible event for
certain phospholipids leading to a loss of normal plasma membrane form and function (Quinn,
1985).
2.4. Spermatozoal Changes in Response to Cryopreservation
Cryopreservation has been reported to cause further changes in spermatozoal plasma
membrane structure as a response to decreasing temperatures, and those changes are similar
to changes seen at capacitation, including elevated intra-cellular calcium, in preparation for
acrosomal exocytosis (Watson, 2000). During capacitation there is an efflux of cholesterol from
the plasma membrane. A similar cholesterol efflux has been reported in spermatozoa of boars
(Maldjian et al., 2005) and bucks (Chakrabarty et al., 2007) after cryopreservation, both studies
showed a reduction in plasma membrane cholesterol content and a positive correlation
between decreasing plasma membrane cholesterol levels and an increased proportion of
acrosome-reacted spermatozoa present after thawing, the latter being measure using
fluorescent lectin PNA and propidium iodide (Maldjian et al., 2005). The presence of
intramembranous cholesterol has a protective effect, as its presence during decreasing
environmental temperature will block phospholipid coalescence, thus maintaining membrane
fluidity. The addition of 1.4 mg/ml of cholesterol-loaded cyclodextrins (CLC) to egg-yolk diluents
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has resulted in higher percentages of motile and viable cells of bull semen (Purdy and Graham,
2004). In the stallion, the addition of 1.5 mg/ml to a freezing extender had a beneficial effect
(Moore et al., 2005). In addition to the loss of cholesterol, both studies demonstrated a
significant change from long chained polyunsaturated fatty acids to saturated fatty acids
(Maldjian et al., 2005, Chakrabarty et al., 2007). This change may not be reversible, making the
membrane more hydrophobic, which may be a protective mechanism for the cell. Chakrabarty
et al., (2007) suggested that the presence of egg yolk and its close adherence to the plasma
membrane may facilitate the uptake of exogenous saturated fatty acids by the spermatozoal
plasma membrane.
The cryopreservation process can cause irreversible damage to spermatozoa. There are
four main causes of spermatozoal damage that occur during the cryopreservation process: ice
formation; reactive oxygen species; osmotic stress; and apoptotic-like changes.
2.4.1 Ice Crystal Formation
The “two factor hypothesis”, proposed by Mazur (1984) states that intracellular ice,
formed when cells are cooled rapidly, kills cells by either chemical toxicity or osmotic stress,
and by mechanical damage caused by the phase separation of solution and crystal growth.
However, more recent spermatozoal-specific studies have demonstrated that intracellular ice
formation is unlikely to occur at currently used cooling rates during cryopreservation, and that
spermatozoal damage is not as a result of intracellular ice crystal formation (Morris, (2006);
Morris et al., (2007)). Using cryo-scanning electron microscopy Morris et al., (2007)
demonstrated no apparent ice crystal formation in stallion spermatozoa cooled at rates from
0.3 to 3000 °C/min in the presence of a glycerol-based freezing extender. Similar studies in men
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(Morris, 2006) have demonstrated that intracellular ice formation is not present when
spermatozoa are rapidly cryopreserved at rates of up to 3000 °C/min. For semen packaged in
0.5-ml straws, using a conventional extender, the cooling rate is approximately 60 °C/ min,
when straws are suspended 4 cm above liquid nitrogen, in an enclosed container with a vapor
temperature of 160 °C (Amann and Pickett, 1987, Watson, 2000).Previously mentioned studies
concluded that the loss of spermatozoal viability during cryopreservation is most likely
associated with accompanying extra-cellular osmotic pressure changes, during cooling and
thawing, and not direct damage caused by intra-cellular ice crystal formation.
2.4.2. Osmotic Stress
Specific steps of cryopreservation expose spermatozoa to periods of hypo- and
hyperosmotic extra-cellular environments. Initially the addition of spermatozoa to a hyperosmotic freezing extender will result in a period of cellular dehydration as water and permeable
cryoprotectants (e.g. glycerol) equilibrate across the plasma membrane. The length of time
required for equilibration is associated with the permeability of the intra-cellular
cryoprotectant to equilibrate. A second period of osmotic stress occurs during thawing,
spermatozoa still in thawed freezing extender are initially exposed to a hypo-osmotic
environment created by melting ice crystals and as a result there is an increase in cell volume
until solute concentration finally equilibrates.
Stallion spermatozoal cell volume, motility and viability change in response to
extracellular osmolality (Pommer et al., 2002). Spermatozoal cell volumes change after
exposure to hypo-osmotic fluid (75 and 150 mOsm/kg) and hyper-osmotic fluid (450, 600 and
900 mOsm/kg), and all spermatozoa were able to recover initial cell volume upon return to iso13

osmotic conditions (300 mOsm/kg). A change in spermatozoal total motility was observed, with
a significant decrease in all hypo- and hyper-osmotic conditions, and only spermatozoa exposed
to 450 mOsm/kg conditions were able to regain initial total motility. In addition it was
demonstrated that spermatozoa returned to the control solution (300 mOsm/kg) from 75, 150
and 900 mOsm/kg treatments showed significantly lower cell viability. It has been suggested
that this dramatic change in cell volume may produce damage in a number of sperm
compartments, including plasma membrane and mitochondria (Pommer et al., 2002).
Altering the glycerol in the spermatozoal environment to improve cryoprotection will
have detrimental effects on spermatozoal motility and viability. Ball & Vo, (2001) showed that
when increasing concentrations of glycerol were used, there was a decrease in equine sperm
motility. In addition they demonstrated that spermatozoa equilibrated with glycerol and then
abruptly returned to isosmetric conditions suffered a decrease in motility. When glycerol was
used to increase osmolality, there was a decrease in viability above 1200 mOsm/kg. They also
showed a significant decline in mitochondrial membrane potential after an abrupt return to
isosmotic conditions. Interestingly there was no change in acrosomal-intact spermatozoa,
despite the decrease in the number of viable spermatozoa. If after thawing, the glycerol-loaded
spermatozoa are abruptly transferred to conditions exceeding their osmotic tolerance, loss of
motility, viability and potentially cell lysis may result (Ball, 2008). Attempts to minimize osmotic
stress during cryopreservation have included step-wise dilution of cryoprotectants (Wessel and
Ball, 2004), evaluation of alternative more-permeable cryoprotectants to glycerol (Squires et
al., 2004) and increasing membrane stability by incorporating cholesterol-loaded cyclodextrns
(CLC) in freezing diluents (Squires, 2005).
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2.4.3. Reactive Oxygen Species
Oxidative stress is an imbalance between the production of reactive oxygen species
(ROS) and the cellular capacity to detoxify ROS or to repair the resulting damage. Reactive
oxygen species are produced during normal oxidative metabolism (Ball, 2008), and
cryopreservation will result in an excess production of ROS. Equine spermatozoa are more
susceptible to oxidative stress than other species due the high concentration of unsaturated
fatty acids present in cellular membranes (Squires, 2005). Reactive oxygen species are products
derived from the reduction of diatomic oxygen (O2), and include radicals and other reactive
products (Ball et al., 2001). Radicals are atomic or molecular species that have unpaired
electrons in their orbits, making them unstable as they will be involved in cellular reactions in
order to displace or share these electrons. Reactive oxygen species have an important role in
spermatozoal capacitation, and an imbalance in either the production or degradation of ROS
can adversely affect spermatozoal survival and function (Baumber et al. 2003, Ball, 2008).
The superoxide anion (O2-), the most common ROS produced by spermatozoa, is rapidly
converted to hydrogen peroxide (H2O2) by the scavenger superoxide dismutase (O2- + O2- + 2H+
→ H2O2 + O2) (Ball et al. 2001). The superoxide anion increases in equine spermatozoa exposed
to hypo and hyperosmotic extracellular conditions (Burnaugh et al. 2010). Hydrogen peroxide is
more stable than O2- and can more readily cross plasma membranes, and has been shown to be
the major ROS responsible for human and equine spermatozoal injury (Aitken et al. 1992,
Baumber et al. 2000). The other two common ROS scavengers described in semen are catalase
(which catabolizes H2O2) and glutathione peroxidase system, which reduces H2O2 (Ball, 2008).
Spermatozoa have limited endogenous sources of these scavengers and rely predominantly on
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extracellular sources, namely seminal plasma (Varner and Johnson 2007). Since the presence of
excess seminal plasma can be detrimental to spermatozoal longevity and cryopreservation and
is commonly removed prior to cryopreservation (Moore et al., 2005), the removal of ROS
scavengers leaves spermatozoa particularly vulnerable to ROS during cryopreservation.
The production of ROS by equine spermatozoa is from either sperm-specific NADPH
oxidase (NOX 5) present in the plasma membrane of the spermatozoal head or from
spermatozoal mitochondria (Sabeur & Ball 2006, 2007). The generation of ROS by NOX 5 in the
spermatozoal head may be a necessary step in the induction of capacitation, resulting in
tyrosine phosphorylation (Baumber et al. 2003). In cryopreserved equine spermatozoa the
principle source of ROS generation is due to electron leakage from the mitochondrial electron
transport chain (Sabeur and Ball 2006). The leakage of electrons results in the formation of the
superoxide ion, which is rapidly converted to of H2O2 by superoxide dismutase.
The generation of H2O2 by equine spermatozoa is five-fold greater in amount by cryodamaged spermatozoa compared to control spermatozoa (Ball et al., 2001). The iatrogenic
generation of ROS has been demonstrated in spermatozoal samples, resulting in a decrease in
spermatozoal motility, but not viability, acrosomal integrity or mitochondrial membrane
potential (Baumber et al. 2000). The presence of catalase, but not superoxide dismutase,
appeared to maintain normal motility when spermatozoa were exposed to oxidative stress,
indicating that H2O2 was the main ROS responsible for the observed changes. This effect on
motility by H2O2 has also been demonstrated in human spermatozoa, possibly caused by a
decrease in ATP without a significant decrease in mitochondrial membrane potential
(Armstrong et al. 1999). In a follow-up equine study, the presence of H2O2 and not superoxide
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anion appears to be the ROS responsible for DNA fragmentation, but the exact mechanism of
damage is undetermined (Baumber et al. 2003). Cryopreservation causes oxidative stress, and
spermatozoal damage is caused by H2O2, whether spermatozoal damage is morphologically
apparent or not.
2.4.4. Apoptotic-Like Changes
Apoptosis is defined as the process of programmed cell death that affects single cells
and induces a series of cellular, morphological and biochemical alterations, leading to cell
suicide, without any related inflammation in the surrounding tissue (Ameison 1996). The
initiation of apoptosis is caused by two distinctly different pathways, the intrinsic and extrinsic
pathways. The intrinsic pathway in spermatozoa is activated by stress induced cell changes;
these stresses include oxidative stress, osmotic stress, heat, hypoxia, DNA damage or lack of
pro-survival factors (Ball et al., 2008, Glazer et al., 2009, Peña et al., 2011). These stressors
result in activation of the mitochondrial-dependent pathway of apoptosis and subsequent
mitochondrial release of cytochrome c, which activates caspases 3, 7, and 9, resulting in cell
death. The extrinsic pathway is activated by plasma membrane receptor-ligand binding leading
to activation of caspases.
Cryopreservation can cause apoptotic like changes to equine spermatozoa. A number of
apoptotic like changes have been demonstrated in equine spermatozoa after cryopreservation
including decreased mitochondrial membrane potential, altered membrane structure, caspase
activation (Brum et al.,2008), and increased DNA fragmentation (Brum et al., 2008, Baumber et
al., 2003). Active caspases 3, 7, and 9 have been detected in sperm and are considered a
measure of mitochondrial apoptotic changes (Ortega-Ferrusola et al., 2008).
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2.5. Spermatozoal Evaluation
2.5.1. Motility
The evaluation of spermatozoal motility is considered one of the most important
measures of spermatozoal quality. Poorly motile or immotile spermatozoa are considered
incapable of fertilization without the help of assisted reproductive techniques. However
spermatozoal motility alone should never be used to predict fertility, as there are many other
requirements of spermatozoa for the fertilization of an oocyte.
Motility evaluation can be performed using light microscopy. A drop (5 to 10 µl) of raw
or extended semen is placed on a pre-warmed microscope slide, covered with a coverslip, and
the total and progressive motility at 100x, 200x or 400x magnification evaluated in four to six
fields. To overcome the subjectivity of microscopic evaluation, computer assisted sperm
analysis (CASA) systems have been developed. This technique offers an objective and rapid
method of motility analysis by recording 40 to 60 frames/second of spermatozoal movement
(Baumber-Skaife, 2010). The recommended evaluation concentration is 25 to 40 x 106/ml
(Varner et al., 1991). Characterization of motility is based on a number of defined parameters,
including total motility (TM), progressive motility (PM), curvilinear velocity (VCL), average path
velocity (VAP), straight line velocity (VSL), lateral head displacement (LHD), beat cross
frequency (BCF), linearity (LIN), straightness (STR), wobble (WOB), and circularly motile
spermatozoa (CIR). Using this technique variability is not totally eliminated as there is currently
no universally accepted definitions or values for the above parameters, with some variation
between laboratories reported (Hoogewijs, 2011).
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2.5.2. Concentration
Concentration evaluation of ejaculates is a fundamental part of semen evaluation and
allows a calculation of total-sperm number. The current gold standard method of concentration
measurement is the hemacytometer (Baimber-Skaife, 2010). The most commonly used design
is the Neubauer hemacytometer. Other commonly used methods of concentration
measurement include spectrophotometric analysis, and more recently developed
NucleoCounter®SP-100™ (ChemoMetec A/S, Denmark), which utilizes the nucleic stain
propidium iodide.
To calculate concentration using a hemacytometer, raw semen a 1:100 dilution with
formal buffered saline (FBS). The chamber space between the hemacytometer and coverslip is
loaded on both sides of the hemocytometer, and then given time for the spermatozoa to settle.
Using light microscopy at 400x, all the spermatozoal heads are counted within the 25 central
squares. The counting of spermatozoa is repeated on the second grid, and the average numbers
of spermatozoa present is calculated, which represents the sperm concentration in millions/ml.
Possible sources of variation include difference in hemacytometer design and operator error. At
least two chambers should be counted, with no greater than a 10% difference in spermatozoa
counted between chambers. It is suggested that up to four chambers should be counted to help
reduce error (Christensen et al., 2005).
2.5.3. Morphology
Spermatozoal morphology is an important component of semen evaluation.
Abnormalities in spermatozoal shape can reflect abnormal spermatogenesis; these
abnormalities may potentially affect spermatozoal fertilizing capacity (Baumber-Skaife, 2010).
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Morphology is examined by phase contrast or differential interference contrast (DIC)
microscopy, at 1000x oil immersion. This can be done by placing a drop (5 to 10µl) of raw
semen diluted with formalin buffered saline (FBS) on a microscope slide, covered with a cover
slip, and then examined under by microscopy. Alternative methods of evaluation include using
background or cellular stains. At least 100 to 200 spermatozoa should be evaluated and
morphological defects noted. Typical abnormalities noted include head shape, acrosome form,
proximal or distal droplets, mid-piece abnormality, coiled and kinked tail, detached heads and
round cells. Spermatozoa can have more than one defect. It is also possible to induce
morphological defects through poor sample preparation; iatrogenic abnormalities include
reflected mid-pieces (cold-shock) and coiled tails (hypo-osmotic shock) (Baumber-Skaife, 2010).
2.5.4. Plasma Membrane & Acrosome Integrity
The assessment of spermatozoal viability using fluorescent probes uses a combination
of two stains, one that will identify living cells and one that identifies non-viable (dead) cells.
The level of staining can be assessed by fluorescent microscopy or flow cytometry. The
combination of nucleic acid stains SYBR-14 and propidium iodide (PI) to assess spermatozoal
viability was developed by Garner and Johnson (1995). These nucleic acid stains consist of one
that is membrane permeate (SYBR-14) and the other that is impermeate to the cell membrane
(PI). It has been used to assess viability in bull, boar, ram, rabbit, mouse, stallion and human
spermatozoa. Spermatozoa that stain with SYBR-14 (fluoresce green) are viable, and those
stained by PI fluoresce red and are non-viable.
Evaluation of acrosome status can be performed using flow cytometry on cells
stained with fluorescein isothiocyanate (FITC) conjugated with either peanut agglutinin (PNA) or
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Pisum sativum agglutinin (PSA). The PNA lectin is preferred over PSA because its binding is
more specific, being limited to the outer acrosomal membrane (Cheng et al., 1996). The PNA
lectin binds to β-galactose moieties of the outer acrosomal membrane of reacted or damaged
acrosomes; therefore, spermatozoa with non-reacted acrosome will not bind the FITC-PNA
conjugate (no fluorescence), whereas spermatozoa with a reacted or damaged acrosome will
bind FITC-PNA conjugate and fluoresce green (Rathi et al., 2001).
2.5.5. Spermatozoal Chromatin Analysis
The evaluation of spermatozoal DNA has now become an important test of fertility in
the stallion. Per cycle pregnancy rates range from 45 to 75%, and despite this very wide range
in fertility, semen parameters (e.g. motility) can be quite similar between stallions with
different per-cycle pregnancy rates. The sperm chromatin structure assay (SCSA) test was first
proposed by Evanson et al., (1980), to measure DNA quality. The SCSA test only evaluates the
DNA and not the nucleoproteins. The principal of the test uses a metachromatic fluorochrome,
acridine orange (AO), to evaluate the proportion of single to double stranded DNA present in
spermatozoa. Acridine orange will fluoresce either red (single-stranded DNA) or green (doublestranded DNA). Single-stranded DNA is associated with spermatozoa unable to maintain a
double helix. Either heat or an acid can be used to test the DNA’s ability to maintain a double
helix. Susceptibility to denaturation is correlated with the level of DNA strand breaks, which can
be caused by a multitude of factors including idiopathic apoptosis, oxidative stress, heat stress,
radiation injury, or protamine deficiency. Spermatozoa affected with this type of damage can
appear normal based on other frequently used laboratory tests, including motility, morphology
and membrane integrity.
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Green Fluorescence

COMPαt
Red Fluorescence

Figure 2.1 Flow cytometric presentation of Sperm Chromatin Structure Assay analysis
data. Green fluorescence indicates a spermatozoal population with normal undamaged
chromatin. Red fluorescence represents the cells outside the main population that have
chromatin damage.

SCSA uses flow cytometry to evaluate fluorescence and the results are depicted in a
scatter-gram, with green fluorescence on the y-axis and red fluorescence on the x-axis. The
majority of normal spermatozoa will emit a green fluorescence (main population), and are
found in the upper left-hand potion of the graph. The damaged spermatozoa will fluoresce red
and be located outside the main population and along the x-axis. The terms used to describe
this population of abnormal cells, include the percentage of cells outside the main population
(COMPαt) and the degree of DNA denaturation (Meanαt) (Figure 2.1). The αt is calculated as the
ratio of red fluorescence to red and green fluorescence, with the COMPαt and Meanαt values
calculated from spermatozoal flow cytometric histogram analysis. Love and Kenney (1998)
demonstrated a correlation between the COMPαt and the seasonal pregnancy rate (Table 2.2),
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in the absence of other overt reproductive abnormalities and apparent disease, thus
demonstrating an association between denaturation and reduced fertility.

Table 2.2 The association between DNA denaturation and fertility (Adapted from Love and
Kenney, 1998).
Fertility Groups
1
2
3
Seasonal pregnancy rate

93a

86b

73c

% Pregnant/cycle

82a

55b

39c

% Total motile

84a

74b

63c

% Morphologically normal

69a

46b

46b

% COMPαt

12a

17b

25c

*Superscripts within rows are significantly different (p=0.05)

2.6. Iodixanol
2.6.1. Introduction
Iodixanol (systematic name 5,5’-[(2-hydroxy-1,3-propanediyl)-bis(acetylamino)]
bis[N,N’-bis(2,3-dihydroxypropyl-2,4,6-triiodo-1,3-benzenedicarboxamide] (Figure 2.2) was
developed as an imaging contrast agent for radiography.
It has been evaluated as a contrast agent for endoscopic retrograde
cholangiopancreatography, cardioangiography, cerebral angiography, urography and aortic
femoral angiography. It is now used predominately as density gradient for the separation and
isolation of viable cells (Kjeken et al., 2001), and as a cushion medium for centrifugation. There
are a number of commercially prepared iodixanol cushion media available (Optiprep™,
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Accurate Chemical, Westbury, NY; Eqcellsire®Component B, IMV, L’Aigle, France; Cushion
Fluid Minitube, Mt Horeb, WI). There is only one preparation with a known percentage of
iodixanol (Optiprep™, 60% w/v).

Figure 2.2 The chemical structure of an iodixanol (5,5’-[(2-hydroxy-1,3-propanediyl)bis(acetylamino)] bis[N,N’-bis(2,3-dihydroxypropyl-2,4,6-triiodo-1,3-benzenedicarboxamide])
molecule.

2.6.2 Iodixanol as a Contrast Agent
Iodixanol has a number of chemical properties, including high molecular weight and
inertness, which suggest it may be safely used with biological material. Iodixanol is a non-ionic
dimer, with an osmolarity similar to that of blood (270-320 mOsm/kg). Initial iodinated contrast
agents had osmolarities 5 to 8 fold greater than blood. Iodixanol is considered a safe contrast
agent. Iodinated contrast agents are commonly used in human medicine, with up to 70 million
injections reported worldwide per year (Christiansen, 2004). Iodixanol has become a popular
contrast agent because it displays a lower incidence of discomfort (heat and pain) compared to
other iodinated contrast agents after injection. Although rare, the reported side effects include
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both immediate and delayed reactions to the contrast media in a variety of body systems
including; cutaneous (erythema); cardiovascular (hypotension, vasodilation, tachycardia,
cardiac arrest); gastro-intestinal (nausea and vomiting); and respiratory (dyspnea,
broncospasm, laryngeal edema). The exact pathogenesis of these reactions is unknown, but
they are typical of hypersensitivity-like reactions, including mast cell and basophil dose
dependent histamine release (Tumlin et al., 2006). The reported reaction rates for iodixanol
range from 0.04% for severe reactions to 3% for delayed reactions (ADIS Data Information,
2006). In a study by Davenport et al., (1999) the toxicity of iodixanol in the lung and its
absorption from the peritoneal cavity in rabbits was studied. In the lung it was considered a
good and safe contrast agent because of its isotonicity with reduced pulmonary edema
compared to iohexol (another iodinated contrast medium, osmolality 920 mOsm/kg), after
administration through an endotracheal tube. After intra-peritoneal administration, iodixanol
was shown to be rapidly absorbed within 1 hour in 89% of treated rabbits, after intra-peritoneal
administration. Iodixanol is eventually excreted in the urine by glomerular filtration. After
intravenous injection, 97% of an injected dose is excreted unchanged in the urine after 24 hours
in healthy patients, and in patients with renal impairment, 8.2% is reportedly recovered in the
feces (Spencer and Goa, 1996).
Iodixanol is a large, water-soluble and nonionic molecule, and therefore is not expected
to pass easily into cells. Kjeken et al., (2001) demonstrated iodixanol uptake by hepatic Kupffer
cells of rats. Kupffer cells of the liver demonstrate phagocytic activity like macrophage cells, and
may be more capable of macro-endocytosis as they play an important part in antigen uptake
and antigen presentation. It is unlikely that spermatozoa are able to take up iodixanol into their
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intracellular compartment. This is especially unlikely to occur when using freezing extenders
that have short or no equilibration times.
2.6.3 Iodixanol and Semen Processing
Iodixanol was first proposed as a density gradient for the separation of spermatozoa by
centrifugation, and it has been demonstrated to perform similarly to Percoll (Gellert-Mortimor
et al., 1988). McCann and Chantler, (2000) compared Percoll and IxaPrep (a polysucrose and an
iodixanol based density centrifugation preparation, respectively), and evaluated motility,
spermatozoal longevity, morphology and acrosome reaction. Percoll fractions demonstrated
higher spermatozoal recovery and better longevity, but there was no significant difference in
morphology or percent acrosome-reacted cells. In contrast Yang et al., (1998), demonstrated no
difference in motility and longevity between the two density gradient preparations.
In a study by Ford et al., (1994), bovine spermatozoa were exposed to 20 to 25%
iodixanol for one hour without any deterioration in morphology or motility. Harrison, (1997)
studied the use of iodixanol as a two layer density gradient for the separation of motile human
spermatozoa by centrifugation. Two layers of iodixanol selected from 25, 35, 40, 45, 50, 60, 70,
80 and 90% dilutions, were used to separate 25 x 106 progressively motile spermatozoa by
centrifugation at 400 x g for 15 to 20 minutes. In addition to recovery rates, the toxic effects of
iodixanol on human spermatozoa and mouse embryos were investigated. Fresh normal
spermatozoa, previously separated by 30/45% and 25/40% gradients, were incubated for 72 hr
before re-evaluating progressive motility. Murine embryos were incubated for 72 hr at 37°C in a
5% CO2 environment, after 25 µl of 25, 40 or 100% iodixanol was placed below the embryos and
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culture medium. Results showed that greater than 80% of spermatozoa retained their motility
and 82 to 86% of embryos developed to the blastocyst stage. There were no controls used in
this study, but the author concluded these results were satisfactory.
2.7 Spermatozoal Cushioned Centrifugation
The use of fresh cooled or cryopreserved semen is now a mainstay of equine breeding
programs worldwide. One of the techniques used to process semen for both fresh-cooled
shipment and cryopreservation is centrifugation. Centrifugation of spermatozoa is performed
to remove seminal plasma, and replace it with a chilling or freezing extender, as the retention
of seminal plasma may result in a decrease in fertility for the spermatozoa of some stallions
(Moore et al., 2005). The properties of an ideal centrifugation protocol are the maximum
recovery of spermatozoa after centrifugation with minimal spermatozoal damage. The effects
of centrifugation on equine spermatozoa have been intensively studied, with results reaching
no definitive conclusion. As a result, centrifugal forces used to process semen are kept
conservatively low. Forces from 400 to 600 x g are currently considered industry standards
(Hoogewijs et al., 2011), and it is accepted that losses of up to 25% will occur when diluted
semen is centrifuged at 400 to 600 x g for 10 to 15 minutes (Loomis & Graham, 2008). Raising
centrifugation forces to 900 x g has been shown to have no detrimental effect on total and
progressive motility, viability and acrosome integrity, with a 75% recovery rate of spermatozoa
reported at 900 x g (Len et al. 2010).
Another use for iodixanol is cushion-centrifugation. This process involves placing an
inert, high-molecular weight solution (iodixanol) below the spermatozoa prior to centrifugation
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to help protect against the mechanical forces that spermatozoa are subjected to during
centrifugation. The first report of using iodixanol as a cushion for centrifugation of equine
spermatozoa was by Revell (1997). The use of iodixanol as a centrifugation cushion media has
now become a popular technique to improve current centrifugation protocols. The current
popularity of centrifugation cushions is based on reports of higher recovery rates of
spermatozoa, which subsequently results in more spermatozoa for preservation and larger
profits for stallion owners. Significantly higher recovery rates of 99-107% for three of four
treatments (Ecot et al., 2005) and 93% for all cushion treatments (Sieme et al., 2006), have
been demonstrated when extended spermatozoa are centrifuged at 1000 x g for 20 minutes
over a cushion, however only one of these studies had similar centrifugation protocols for the
control samples (Sieme et al., 2006). Despite a difference in centrifugation protocols, Ecot et al.,
(2005) showed a significantly higher number of straws/ejaculate, 72 and 92 straws for 600 x g
10 mins (control) and 1000 x g 20 mins, respectively, with equivalent pregnancy rates for
treatments being reported (62.5%).
After centrifugation, the cushion media must be removed before the addition of further
semen extenders (Figure 2.3); it is difficult to remove the cushion media without disrupting or
losing any of the soft spermatozoal pellet. As a result, erring on the side of caution, the cushion
is frequently incompletely removed and some unknown percentage of iodixanol residues
remains. To date only one study (Waite et al., 2009) has demonstrated that the use of iodixanol
had no deleterious effects on equine spermatozoa, with no reported decrease in spermatozoal
motility or DNA damage after cushion centrifugation and storage at 4 °C for 24 hour. Saragusty
et al., (2009) evaluated the effects of incomplete removal of iodixanol during pre-freezing
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centrifugation of bull spermatozoa. The investigators hypothesized that iodixanol residues may
have positive cryoprotective effects, as measured by post-thaw motility, plasma membrane
functionality and viability, and acrosomal integrity. Their results showed that the presence of
iodixanol in fact helped to maintain membrane integrity and longevity.

A

B

Figure 2.3 Post-centrifugation pellet and cushion. The supernatant has been removed from the
conical tubes, and the pellet is the white layer, with the cushion being the clear solution located
underneath the pellet. These pictures demonstrate before (A) and after (B) iodixanol removal. A
cushion residue can be seen in the bottom of the tube in B, with the overlying spermatozoal
pellet.

The objective of this study was to characterize the effects of iodixanol residues present
during the cryopreservation of equine spermatozoa. Our hypothesis was that the addition of
iodixanol would improve equine spermatozoal post-thaw parameters.
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CHAPTER 3
THE INVESTIGATION OF THE EFFECTS OF IODIXANOL DURING EQUINE SEMEN
CRYOPRESERVATION

3.1. Introduction
The objective of this study was to evaluate the effect that 0%, 2.5% and 5% iodixanol
(v/v; Opitprep™, Accurate Chemical, Westbury, NY; 60% iodixanol w/v) in an egg yolk glycerolbased freezing extender (EZ Freezin LE, Animal Reproduction Services, Chino, CA) on equine
spermatozoal total and progressive motility, viability, acrosomal integrity and DNA damage
after cushion free centrifugation. Our hypothesis was that the addition of iodixanol would
improve equine spermatozoal post-thaw parameters.
3.2. Materials and Methods
Six stallions were used for this study; four were from the LSU Department of Animal
Sciences, one from the LSU School of Veterinary Medicine teaching herd and one from a client
of the LSU School of Veterinary Medicine. The stallions ranged from five to 29 years old. Stallion
semen was collected between August and November in 2010 and 2011. All procedures were in
accordance (or approved by) the Louisiana State University Institutional Animal Care and Use
Committee and Clinical Protocols Committee.
3.2.1. Semen Collection
Semen was collected from all stallions at least seven times in an everyday collection
schedule to deplete the extra-gonadal spermatozoal reserves. After seven consecutive days of
collection, daily sperm output (DSO) for each stallion had been achieved, as total spermatozoal
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collected had stabilized, and cryopreservation was performed on the next three ejaculates,
collected on 24 h intervals.
Before semen collection the stallion was teased, until the stallion achieved an erection,
the penis washed with cotton soaked in warm water to remove smegma, and the excess water
was removed with a clean towel. Stallions mounted an estral mare or phantom, and semen was
collected into a Hannover artificial vagina (Animal Reproduction Services, CA), temperature 5051 °C. The artificial vagina was equipped with a disposable plastic liner and an in-line nylon
mesh filter to obtain a gel-free semen sample. After the semen was collected, the filtered
ejaculate was diluted 1:1 with a milk-based semen extender (EZMixin Original Formula, Animal
Reproduction Services, CA), which had been warmed to 37° C prior to collection. A 2-ml sample
of raw semen was saved for later determination of concentration and morphology, and samples
were transported to the laboratory within 30 min of collection. To account for the variable
distance of collection facility to the laboratory a mandatory waiting period of 30 minutes was
applied to all extended samples before centrifugation. During this holding period the extended
samples were maintained at room temperature in a styrofoam shipping box to protect against
temperature changes and light exposure. The collected samples were not cooled for
transportation in this project, as spermatozoal cooling would have resulted in a temporary
spermatozoal stress which may have had unquantifiable effects on spermatozoal response to
changes during cryopreservation.
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3.2.2. Semen Processing Overview
At the end of the mandatory waiting period, concentration, motility and morphology
were evaluated by hemacytometer, CASA and wet-mount preparation respectively. The
treatment groups were 0%, 2.5% and 5% iodixanol (v/v)) in an egg-yolk based extender (EZ
Freezin LE, Animal Reproduction Services, CA). The calculation of percent iodixanol was based
on the freezing volume that had a final freezing spermatozoal concentration of 200 x 106/ml.
3.2.3. Centrifugation
The extended semen was divided into three equal volumes prior to freezing, and placed
in 15-ml conical centrifuge tubes and centrifuged (Eppendorf 5804, Hamburg, Germany) at 900
x g for 10 min without a cushion. After centrifugation, the supernatant was removed from each
tube, leaving approximately 0.5 ml of the supernatant containing the spermatozoal pellet in the
bottom of the conical tube. Each spermatozoal pellet was then suspended with one of the
freezing extender/iodixanol preparations, to a freezing concentration of 200 x 106/ml.
3.2.4. Concentration
A 100-µL semen aliquot was diluted into 900 µl of FBS to make a 1:10 dilution. A 100-µl
aliquot of the 1:10 dilution was further diluted with 900 µl of FBS, making a 1:100 dilution. The
1:100 dilution was used to fill a Neubauer hemacytometer. The spermatozoal concentration
was determined by counting all the spermatozoal cell heads within the 25 squares surrounded
by the triple lines on both sides of the hemacytometer using a phase contrast microscope at
400x (Olympus BH-2, Olympus America INC., NC). The concentration was the product of the
average of the number of cells counted on both sides, at 106 per ml. This procedure was
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performed, and repeated if required, until the difference between the cells counted from both
sides of the hemacytometer was ≤ 10%.
3.2.5. Morphology
Spermatozoal morphology was assessed with a sample from the 1:10 dilution. A 1-µL
sample was placed on a plain microscope slide and a coverslip was added. Morphological
assessment was performed under 1000x oil immersion using phase contrast microscopy
(Olympus BH-2, Olympus America INC., NC). A total of 100 spermatozoa were counted and
categorized.
3.2.6. Cryopreservation
After supernatant removal, the spermatozoa were re-suspended with prepared freezing
extender (EZ-Freezin LE, Animal Reproduction Services, Chino, CA) and iodixanol (Opitprep™,
Accurate Chemical, Westbury, NY) preparations. Iodixanol was added to the extender (which
had been thawed at room temperature), with the calculation of the percentage iodixanol being
based on a final volume that had a freezing concentration of 200 x106/ml. The mixture was then
inverted repeatedly to ensure complete mixing and distribution. The spermatozoal pellet was
re-extended to a freezing concentration of 200 x106/ml with the prepared treatment freezing
extenders. The extended semen was loaded into 0.5-ml straws. For five of the six stallions, 0.5ml straws were used but had been reduced in length to contain 0.25-ml of semen, thus allowing
a reduced volume but maintaining the same straw circumference and dead space. Spermatozoa
from the sixth stallion were frozen in regular 0.5-ml straws. After the straws were filled, they
were placed on a styrofoam float, with the straws kept 3 cm above liquid nitrogen. Straws
remained in the vapor in an enclosed styrofoam box (22 cm x 26.5 cm x 34 cm, 0.198 m3) for
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ten minutes before being plunged into liquid nitrogen. After cryopreservation straws were
stored in liquid nitrogen for a minimum of 30 days before post-thaw analysis was performed.
3.2.7. Motility
The spermatozoal motility after collection was analyzed by placing 2 µL of 1:1 extended
semen in a 20-µm height, four-chambered slide (Leja Products B.V., The Netherlands) over a
slide warmer at 37°C. The slide was then placed on an optical microscope with a warming stage
at 37°C (Olympus BX41, Olympus America Inc., NC). Using the 20x phase contrast magnification
objective, spermatozoal motility was analyzed program with a computer assisted sperm
analysis program (Sperm Vision® 3.0, Minitube, Verona, WI). Spermatozoa were identified
based on defined parameters (Appendix A), and before final values were stored each recorded
clip was edited and all non-spermatozoal events (e.g. egg-yolk particles) were removed. Mean
percentages of total and progressive motility were assessed from seven fields with a minimum
of 100 spermatozoa in each field.
Motility analysis prior to cryopreservation was performed on each treatment. A 100-µL
aliquot of each treatment (0%, 2.5% and 5%) was collected before straw-filling, placed in a
micro-centrifuge tube, and diluted with 400 µL of centrifuge extender to a final concentration
of 40 x 106/ml for motility analysis. Post-thaw analysis was performed after thawing samples in
a 37°C water bath for thirty seconds. A similar dilution from a sample of thawed semen as
described above was used. Total and progressive motility analysis was performed at 5 and 30
min of incubation at 37 °C.
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3.2.8. Plasma Membrane Integrity
The fluorescent dyes Propidium Iodide (PI) and SYBR-14 (Molecular Probes Inc., Eugene,
OR) were used to assess plasma membrane integrity. Both are nucleic acid fluorescent dyes;
SYBR-14 is able to cross an intact plasma membrane staining the spermatozoa green, and PI is
only able to cross a disrupted membrane causing the spermatozoa to stain red. Therefore green
spermatozoa are considered viable, and red-stained spermatozoa are considered non-viable or
dead.
A 1-µL aliquot from each of the treatment groups was stained to assess the plasma
membrane integrity, by dilution with 200 µL of PBS (pH 7.4 and 320 mOsm) to a final
concentration of 1 x 106/ml. Cells were then initially stained with 2-µL of SYBR-14 and incubated
at 37°C for 10 min in the dark. After incubation, 2-µL of PI was added and incubation continued
for a further 10 min before flow cytometric analysis. A triplicate preparation of each treatment
was made for flow cytometric analysis.
Stained samples were kept in the dark and analyzed with a flow cytometer (C6 Flow
Cytometer, Accuri Cytometer, Ann Arbor, MI) and kept dark until analysis. The flow rate of cells
was set at 100 to 200 cells/sec. Cells were gated to exclude debris based on side-scatter and
forward-scatter characteristics using a dot plot (Appendix B.1). The gated population was then
subjected to green and red light with spermatozoal fluorescence allowing the separation of
spermatozoa from non-spermatozoal events, and viable from non-viable spermatozoa, and
were analyzed using software (Appendix B.2) (CFlowPlus, Accuri Cytometer, Ann Arbor, MI).
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3.2.9. Acrosome Reactivity
A separate 1-µL aliquot of each treatment was stained to assess the change in acrosome
reactivity before and after cryopreservation for each treatment. Acrosome reactivity was
measured by dual staining spermatozoa with a combination of fluorescein-conjugated Arachis
Hypogaea agglutinan (FITC-PNA) and PI. Fluorescein-conjugated Arachis Hypogaea agglutinan
binds to the β-galactose moieties of the outer acrosomal membrane and fluoresces green. The
PI was used to differentiate viable from non-viable spermatozoa.
The 1-µL aliquot was initially diluted with 200 µl of PBS to a concentration of 1 x 106/ml.
Cells were stained first with 2 µL FITC-PNA, incubated at 37°C for 10 min in the dark, then 2 µL
of PI was added, and incubated for a further 10 minutes before analysis by flow cytometry, at a
flow rate of 100 to 200 cells/sec. A triplicate preparation of each treatment was made for flow
cytometric analysis, and all samples were stored in the dark until analysis.
Stained samples were then analyzed with a flow cytometer (C6 Flow Cytometer, Accuri
Cytometer, Ann Arbor, MI) using quadratic gating (Appendix B.3). Cells were initially gated to
exclude debris based on side-scatter and forward-scatter characteristics using a dot plot, and
florescence analysis was subsequently performed on eleven thousand events, which were
quadrant gated. Spermatozoa were analyzed as four groups, viable spermatozoa non-reacted
acrosome, viable spermatozoa reacted acrosome, non-viable spermatozoa non-reacted
acrosome and non-viable spermatozoa reacted acrosome (CFlowPlus software, Accuri
Cytometer, Ann Arbor, MI).
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3.2.10. Sperm Chromatin Structure Assay
Sample collection for SCSA was performed immediately after the addition of the
prepared freezing treatments. A 0.5-ml aliquot from each of the freezing extender treatments
was placed in 1.0-ml cryovials (Sigma-Aldrich©, St. Louis, MO), and snap-frozen in liquid
nitrogen (LN). Samples were stored in LN for at least 30 days before analysis.
Individual samples were thawed in a 37°C water bath. Aliquots of approx 2-µl of thawed
semen were mixed with 198 µl of a buffered isotonic solution (0.186 g disodium EDTA, 0.79 g
Tris-HCL, 4.38 g NaCl, in 500 ml deionized water, pH 7.4). Samples were then combined with
400 µl of a detergent solution (pH 1.2; 2.19 g NaCl, 1.0 ml of 2 M HCL, 0.25 ml Triton-X, qs. 250
ml deionized water) for 30 sec, and then 1.2 ml of acridine orange solution (3.8869 g citric acid
monohydrate, 8.9429 Na2HPO4, 4.385 g NaCl, 0.17 disodium EDTA, 4.0 µg/ml acridine orange
stock solution (1 mg/ml), qs. 500 ml water, pH 6.0) was added to the sample, and processed
immediately (30 sec) on a flow cytometer (FACScan; Becton Dickinson, Mountain View, CA).
After 30 sec, 11000 events were recorded for analysis, at a flow rate of 100 to 200 cells/sec.
During preparation and evaluation of individual samples, the buffered solution, detergent
solution and acridine orange solutions were all kept in an ice bath, and all sample handling was
performed in a darkened room.
3.2.11. Extender Osmolality
The extender osmolality after addition of iodixanol was measured using a vapor
pressure osmometer (VAPRO 5520, VAPRO® WESCOR, Logan, UTSolutions of 0%, 2.5% and 5%
iodixanol in freezing extender (v/v) solutions were prepared. A 10-µL sample of each
preparation to be tested was aspirated and inoculated onto a solute free paper disc. The
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inoculated disc was then inserted and locked into the sample chamber and the osmolality
measured. Samples were measured in duplicate, with the mean value recorded.
3.2.12. Statistical Analyses
The mean (± S.E.) percentage pre- and post-thaw total motility, progressive motility,
viability, acrosome reactivity, COMPαt and MEANαt were analyzed using the Shapiro Wilk’s test
to evaluate if data followed a normal distribution. The only parameter that followed a normal
distribution was MEANαt and an ANOVA was performed and where a significant interaction of
treatment was observed (p<0.05), a Tukey-Kramer post-hoc test was applied. For measured
parameters that did not follow a normal distribution, a binomial logistical regression was
performed using spermatozoal (events and trials) numbers for each measured parameter
(Appendix C), and results are presented in percentage. Where a significant interaction of
treatment was observed (p<0.05), a Tukey-Kramer post-hoc test was applied. All statistical
analysis was performed using statistical analysis software (SAS 9.3, SAS Institute Inc, Cary, NC).
3.3. Results
Total motility results did not follow a normal distribution and therefore a binomial
logistic regression was performed (Appendix C.1). The 0% post-thaw TM was found to be
significantly higher than that of 2.5% iodixanol treatment, and neither 0% or 2.5% treatment
groups were significantly different from the 5% treatment group. There was a significant
difference between pre- and post-cryopreservation TM for all treatment groups (Table 3.1).
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Table 3.1 Mean (±SE) spermatozoal total motility (TM) percentage (%) pre- and postcryopreservation (n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender.
Treatment
Pre-Freeze TM (%)
Post-Thaw TM (%)
0 % Iodixanol

65.16 ± 3.28%a1

31.93 ± 3.1%a2

2.5 % Iodixanol

64.65 ± 3.3%a1

28.1 ± 2.9 %b2

5 % Iodixanol

64.14 ± 3.3%a1

30.4 ± 3.1%ab2

Values within column with different letter subscript are significantly different (P<0.001).
Values within rows with different number subscript are significantly different (P<0.001).

Progressive motility results did not follow a normal distribution and was analyzed using
a binomial logistic regression (Appendix C.2). The 0% post-thaw PM was found to be
significantly higher than 2.5% iodixanol treatment, and neither 0% or 2.5% treatment groups
were significantly different from the 5% treatment group. There was a significant difference
between pre- and post-cryopreservation PM. There was a significant difference between preand post-cryopreservation PM for all treatment groups (Table 3.2).

Table 3.2 Mean (±SE) spermatozoal progressive motility (PM) percentage (%) before and after
cryopreservation (n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender.
Treatment
Pre-Freeze PM (%)
Post-Thaw PM (%)
0% Iodixanol

53.75 ± 4.44%a1

23.72 ± 3.23%a2

2.5% Iodixanol

53.44 ± 4.44%a1

20.19 ± 2.87%b2

5% Iodixanol

52.5 ± 4.44%a1

21.94 ± 3.04%ab2

Values within column with different letter subscript are significantly different (P<0.001).
Values within rows with different number subscript are significantly different (P<0.001).
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Thirty minute post-thaw TM results did not follow a normal distribution and was
analyzed by a binomial logistic regression (Appendix C.3). The 2.5% post-thaw TM was found to
be significantly lower than the 0% and 5% iodixanol treatment groups, and neither 0% nor 5%
treatment groups were significantly different (Table 3.3).

Table 3.3 Mean (±SE) spermatozoal thirty minute post-thaw TM percentage (%) after
cryopreservation (n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender.
Treatment

Thirty Minute Post-thaw Total
Motility (%)

0% Iodixanol

40.25 ± 3.52%a

2.5% Iodixanol

36.77 ± 3.41%b

5% Iodixanol

39.53 ± 3.49%a

Values within column with different letter subscript are significantly different (P<0.001).

Thirty minute post-thaw PM results did not follow a normal distribution and was
analyzed by a binomial logistic regression (Appendix C.4). The 2.5% post-thaw PM was found to
be significantly lower than the 0% and 5% iodixanol treatment groups, and neither 0% nor 5%
treatment groups were significantly different (Table 3.4).
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Table 3.4 Mean (±SE) spermatozoal thirty minute post-thaw PM percentage (%) after
cryopreservation (n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender.
Treatment

Thirty Minute Post-thaw
Progressive Motility (%)

0% Iodixanol

30.41 ± 3.87%a

2.5% Iodixanol

27.17 ± 3.62%b

5% Iodixanol

28.94 ± 3.76%a

Values within column with different letter subscript are significantly different (P<0.001).

Post-thaw spermatozoal viability results did not follow a normal distribution and was
analyzed using a binomial logistic regression (Appendix C.5). The 5% post-thaw viability was
significantly greater than both the 0% and 2.5%, with the 2.5% being significantly higher than
the 0% treatment group in post-thaw analysis; however, the pre-freeze 2.5% treatment group
had significantly less spermatozoal viability prior to freezing than the 0% and the 5% treatment
groups. There was a significant difference between pre- and post-cryopreservation
spermatozoal viability for all treatment groups (Table 3.5).
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Table 3.5 Mean (±SE) spermatozoal viability percentage (%) before and after cryopreservation
(n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender.
Treatment

Pre-Freeze Viability (%)

Post-Thaw Viability (%)

0% Iodixanol

59.88 ± 6.72%a1

22.97 ± 4.95%a2

2.5% Iodixanol

59.07 ± 6.77%b1

24.14 ± 5.13%b2

5% Iodixanol

62.24 ± 6.57%c1

24.81 ± 5.22%c2

Values within column with different letter subscript are significantly different (P<0.001).
Values within rows with different number subscript are significantly different (P<0.001).

Post-thaw results for damaged or reacted acrosomes did not follow a normal
distribution and was analyzed using a binomial logistic regression (Appendix C.6). Results
showed significantly less reacted or damaged acrosomes for the 0% post-thaw treatment group
compared to the 2.5% and 5% groups, with the 2.5% group having significantly less reacted or
damaged acrosome than the 5% group. There was a significant difference between pre- and
post-cryopreservation acrosome reactivity for all treatment groups, with the 5% pre-freeze
having significantly fewer reacted or damaged spermatozoa than 0% or 2.5%, and then having a
post-thaw value showing significantly more reacted or damaged acrosomes than he 0% or 2.5%
treatment groups (Table 3.6).
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Table 3.6 Mean (±SE) acrosome reactivity percentage (%) before and after cryopreservation
(n=6) with 0%, 2.5% and 5% iodixanol (v/v) in freezing extender.
Treatment

Pre-Freeze Reacted (%)

Post-Thaw Reacted (%)

0% Iodixanol

8.92 ± 1.27%a1

12.88 ± 1.75%a2

2.5% Iodixanol

8.12 ± 1.17%b1

13.5 ± 1.83%b2

5% Iodixanol

7.8 ± 1.13%c1

14 ± 1.13%c2

Values within column with different letter subscript are significantly different (P<0.001).
Values within rows with different number subscript are significantly different (P<0.001).

The post-thaw COMPαt results did not follow a normal distribution and was analyzed
using a binomial logistic regression (Appendix C.7). Pre- and post-thaw results showed
significantly less COMPαt as iodixanol was added. Post-thaw results showed 5% iodixanol
treatment group having significantly better COMPαt than both the 0% and 2.5% groups, with the
2.5% group having significantly better COMPαt than the 0% group post-cryopreservation. Except
for the 0% treatment group, there was a significant difference between pre- and postcryopreservation chromatin denaturation (Table 3.7).
Table 3.7 Mean (±SE) COMPαt (%) before and after cryopreservation (n=6) with 0%, 2.5% and
5% iodixanol (v/v) in freezing extender.
Treatment

Pre-Freeze COMPαt (%)

Post-Thaw COMPαt (%)

0% Iodixanol

16.24 ± 1.05a1

16.75 ± 1.07a1

2.5% Iodixanol

13.28 ± 0.88b1

15.02 ± 0.98b2

5% Iodixanol

14.6 ± 0.96c1

13.8 ± 0.92c2

Values within column with different letter subscript are significantly different (P<0.001).
Values within rows with different number subscripts are significantly different (P<0.001).
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The MEANαt results were normally distributed and an ANOVA was performed. There was
no significant difference either between pre- and post-cryopreservation, or between treatment
groups (Table 3.8).

Table 3.8 Mean (±SE) MEANαt (%) before and after cryopreservation (n=6) with 0%, 2.5% and
5% iodixanol (v/v) in freezing extender.
Treatment

Pre-Freeze MEANαt (%)

Post-Thaw MEANαt (%)

0% Iodixanol

220.91 ± 4.77%a1

223.12 ± 2.41%a2

2.5% Iodixanol

218.08 ± 4.77%a1

224.7 ± 2.52%a2

5% Iodixanol

218.89 ± 4.77%a1

223.6 ± 2.42%a2

Values within column with different letter subscripts are significantly different (P=0.05).
Values within rows with different number subscripts are significantly different (P=0.05).

Measurement of the osmolality for each treatment group freezing extender
combination showed that with increasing concentrations of iodixanol, extender osmolality
decreased (Figure 3.1).
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Figure 3.1 Mean treatment iodixanol in extender osmolality measurement with 0%, 2.5% and
5% iodixanol (v/v) in freezing extender.

3.4. Discussion
In this experiment, the semen from five of the six stallions was cryopreserved in 0.5-ml
straws that had been shortened to a capacity of 0.25-ml. This reduction in straw length was
performed because the stallions at DSO were not producing enough spermatozoa to allow
sufficient samples to be collected in 0.5-ml straws. Whether such low sperm output was due to
normal stallion production, or if there was a seasonal effect could not be determined as the
DSO for these stallions during the physiological breeding season had not been previously
determined. Based on a constant external surface area, the thermodynamic changes of either a
0.5-ml straw or a 0.5-ml straw reduced in length should not differ as both types have a similar
straw circumference. Both 0.5-ml and 0.25-ml straws have been used for cryopreservation in
horses (Love 1989 and Volkman 1987). No significant difference in total and progressive
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motility, intact plasma membranes or intact acrosomal membrane has been demonstrated
when semen was frozen in 0.25-ml or 0.5-ml straws (Nascimento et al., 2008). Additionally the
freezing concentration of 200 x 106/ml (used in this study) has been demonstrated to have
superior total and progressive post-thaw motility than semen frozen and stored in 0.5-ml
straws at 400 x 106 or 800 x 106 /ml when cryopreserved in an egg-yolk based extender (Loomis
and Clark 1998). As a result, if the freezing concentration for each stallion in this experiment
was maintained at 200 x 106/ml in 0.5-ml straws, it is unlikely that there would have been an
effect of straw length exerted on spermatozoa during cryopreservation.
A lactose-egg yolk-glycerol extender (EZ-Freezin LE), was selected for this study because
a period of refrigeration to allow spermatozoa to equilibrate at 4 °C prior to freezing is not
required. As per the manufacturer’s instructions the extender is kept frozen, and allowed to
thaw to 22 °C before extension of the semen. Heitland et al., (1996) demonstrated that a
prolonged pre-freeze cooling was not required for lactose egg-yolk extended spermatozoa.
Stallion spermatozoa are particularly susceptible to damage from 20°C to 5°C when a rapid
cooling rate is used, which can result in disruption of the plasma membrane integrity and
function due to phase transition of phospholipids, alterations in water transport properties
(Devriddy et al., 2002), and physical disruption of spermatozoal plasma and acrosome
membranes (Watson et al., 1987). The exact mechanism of action of egg-yolk is still unknown;
however, it is proposed that the low density lipoproteins (LDL) stabilize the plasma membrane
and forming a protective film around the sperm membrane (Sieme, 2010). Our results
demonstrate that as the percentage of iodixanol increased spermatozoal viability increased.
Iodixanol is a large inert molecule that unlike the egg-yolk LDLs, may not interact with the
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plasma membrane, but the presence of iodixanol may alter the shape of unfrozen channels
present as water crystalizes with falling temperatures. The main disadvantage of using an eggyolk diluent is the opaqueness of egg-yolk particles, which results in significant debris requiring
manual removal from CASA analysis. Egg-yolk particles were also responsible for a large
proportion of the recorded events using flow cytometry due to similar side-scatter and forwardscatter characteristics as spermatozoa.
Reducing the effects of osmotic stress is an important method of improving both postthaw values and also fertilization rates. Osmolality measurement in this study showed that as
Optiprep™ concentration increased, total freezing extender osmolality decreased. This may
partially explain the significantly higher spermatozoal plasma membrane integrity as shown in
this study. Pommer et al., (2002) demonstrated that when spermatozoa were exposed to 900
mOsm/kg, and subsequently returned to isosmolal conditions (300 mOsm/kg), there was a
lower number of viable spermatozoa present than control spermatozoa maintained at 300
mOSm/kg; and that spermatozoa failed to return to pre-treatment levels of motility if
incubated in a solution in excess of 450 mOsm/kg. Although all treatment extenders were in
excess of 900 mOsm/kg in our study, the addition of Optiprep™ resulted in a decrease in
osmolality, this slight decrease in osmolality may explain why there were significantly more
viable spermatozoa present after cryopreservation in the 2.5% and 5% treatment groups
compared to the 0% treatment group.
The presence of iodixanol may alter the formation of extracellular ice crystals during
cryopreservation. As temperatures drop, water crystalizes, leaving solutes and spermatozoa in
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unfrozen channels. The presence of large iodixanol molecules may alter the shape of these
channels. Saragusty et al., (2009) showed a positive effect of iodixanol on both spermatozoal
motility and acrosomal reactivity, and increasing the percentage of iodixanol altered extracellular ice crystal shape and organization (Figure 5). It was noted that a 60% iodixanol (w/v;
Optiprep™) produced fine grainy crystals, while a 2.5 and 5% iodixanol in Andromed®
preparation produced ice crystal dendrites that were tight and well organized. The 2.5%
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Figure 3.2 From Saragusty et al., (2009). Directional cryo-microscopy of A) Phosphate Buffered
Saline B) 2.5% Optiprep™ in Andromed® C) Andromed® D) 5% Optiprep™ in Andromed® E)
Optiprep™ F) 50% Optiprep™ in Andromed®.

iodixanol had an average intra-dendritic width of 8.71 ± 4.03 µm. The authors suggest that
these iodixanol concentrations produce “cell-friendly” ice crystal dendrites, as the typical
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equine spermatozoal head length is 3 to 4 µm. Below 2.5% iodixanol it was noted the ice crystal
dendrites were looser and less well organized. This hypothesis may help to explain the higher
percentage of viable spermatozoa when 5% iodixanol was used in the present study.
We showed that there was significantly less damaged DNA when iodixanol was added. It
is unlikely that iodixanol is membrane permeable or acquired by endocytosis; therefore the
protective effect of iodixanol on DNA must come from either alteration of ice crystal dendrites
(Saragusty et al., 2009), or protection of plasma membranes by reducing osmotic stress.
Reduced plasma membrane damage, as shown in our study, may prevent entry of calcium ions
that have been shown to be associated with activation of the intrinsic apoptotic pathways in
spermatozoa (Watson 2000). In addition, an overall decrease in non-viable cells should result in
decreased ROS production; ROS has been shown to cause increase DNA fragmentation
(Baumber et al., 2003). It was noted during analysis that the 5% treatment group COMPαt prefreeze value was 14.6 ± 0.96% and post-thaw was 13.8 ± 0.92%. This would suggest that
chromatin integrity improved with cryopreservation. The analysis and gating of flow cytometry
results were performed by a single experienced operator, to reduce operator-induced gating
differences. The presence of egg-yolk particles being counted during analysis may have falsely
increased COMPαt results.
If iodixanol has a protective effect, before it can be included in commercially available
freezing extenders in vivo studies need to be performed to examine what effects iodixanol
might have on the endometrium and potential pregnancy in the horse. To date no such studies
have been performed in the horse. There are limited in vitro studies examining the effect of
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iodixanol on reproductive systems in any species. A study by Heglund et al., (1995) examined
the reproductive toxicology of the daily administration of intravenous iodixanol to both male
and female mice. Female rats (n=30) received 0, 1 or 2 grams iodixanol/kg, beginning 15 days
before initiation of a 14-day cohabitation period with untreated males, with treatments
continuing until either euthanasia at day 20 of presumed gestation or until day 21 post-partum.
Male mice were treated with similar dosages from nine weeks prior to mating, through mating,
and then until day 20 of presumed gestation. In both experiments treatment with iodixanol
showed no effect on cycle length, mating performance, pregnancy rate, copulation, litter size
and mean fetal weight. The only abnormalities noted were some transient changes in body
weight and urine consistency in the iodixanol treated groups. Similar studies in the horse would
be cost-prohibitive.
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CHAPTER 4
CONCLUSIONS

The utilization of centrifugation cushions has become a popular technique used in
equine practice for the handling and preparation of semen. Its use has been promoted by
numerous positive studies demonstrating increased spermatozoal recovery rates, without any
increase in spermatozoal damage, thereby making semen centrifugation a more efficient
process. Centrifugation cushions are marketed as allowing increased numbers of mares to be
bred, with resulting increased profits for stallion owners. As a result there are now a number of
iodixanol-based products commercially available, with only one product (Optiprep™) that has a
known iodixanol percentage included in the manufacturer’s data sheet. Despite the increasing
use of iodixanol, to date there has been no equine safety study examining the effect iodixanol
will have on the outcome of semen quality when present during cryopreservation. The amount
of cushion media required varies from 30 µL to 3 ml, depending on what centrifugation vessel is
used and manufacturer’s instructions, but all techniques will result in an iodixanol residue being
retained with the semen during further processing. The attempted recovery of all iodixanol is
hindered by the resultant soft spermatozoal pellet that rests on the cushion after
centrifugation. During the recovery process there is a point where retrieving the iodixanol must
be stopped as it may compromise spermatozoa recovery, with a result that not all iodixanol is
recovered.
There were a number of problems encountered in this study. These included stallion
number and location, and the collection of samples outside the normal physiological breeding
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season for a stallion. There were limited numbers of stallion available for this study and the
stallions used were located within a 15 mile radius of the laboratory. To account for the
handling time, a standard 30 min period was established when the semen was extended and
kept in a styrofoam box to help negate the effects of storage temperature. The age range of the
stallions used was from 5 to 29 years, with an age difference of 16 years between the oldest
and next oldest stallion. Ideally this study should have been performed during the normal
physiological breeding season. Whether there was an effect of season is difficult to establish as
there were no previous semen analysis records available for five of the stallions in this study.
The results of significantly higher plasma membrane integrity as demonstrated in this
study, before and after freezing, with the addition of iodixanol are consistent with the decrease
in freezing extender osmolality as iodixanol percentage is increased. This would suggest a
possible protective mechanism of iodixanol is prevention of osmotic damage to spermatozoal
plasma membranes during cryopreservation. This protective effect may occur either after the
addition of the freezing extender to the spermatozoa, as the glycerol equilibrates across the
plasma membrane or during thawing, when spermatozoa are exposed to a transient hypoosmotic environment. The subsequent retention of an intact plasma membrane will result in
maintaining DNA integrity, as the intact membrane will help prevent apoptotic changes and
formation of ROS which are associated with increased DNA damage. Whether the presence of
large iodixanol molecules create similar spermatozoal-friendly channels for spermatozoa during
freezing, and alter ice crystal formation as shown in a study of bovine cryopreservation
(Saragusty et al. 2009) needs to be demonstrated. A positive cryoprotective effect is suggested
as the 2.5% treatment group had significantly lower pre-freeze plasma membrane integrity, but
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after cryopreservation it had a significantly higher integrity than the 0% treatment group. In
contrast acrosome integrity after cryopreservation deteriorated with the addition of iodixanol,
suggesting that the presence of iodixanol is detrimental to the acrosome’s ability to survive
freezing. This is an unusual finding as the anatomic location of the acrosome in the
spermatozoal head means it is surrounded by a cellular cytoskeleton which would make the
acrosome better protected from the effects of osmotic stress, and suggests whatever plasma
membrane damage that is occurring is regionally located to the spermatozoal head, and the
underlying acrosome.
In conclusion, although this study showed some significant differences of treatment for
total and progressive motility, plasma membrane integrity, acrosomal integrity and DNA
damage, it may be difficult to demonstrate any clinical importance of these changes. A fertility
trial would be the ultimate test to evaluate the effects of iodixanol. The hypothesis of this study
was that the presence of iodixanol would have positive cryoprotective effects, and these results
show that the addition of 2.5% or 5% iodixanol may have some significant cryoprotective
properties. In addition, this study has answered an important question posed frequently by
clinicians regarding what the implications of iodixanol residue inclusion would be.
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APPENDIX A
THE CASA SPERM VISION® 3.0. PARAMETERS USED FOR EQUINE SPERMATOZOAL ANALYSIS


20µM field of view depth



Cell identification: 14 to 80µM2



500 cells or 7 fields



Immotile: AOC < 9.5



Local motile: DSL < 6
o Hyper-active= VCL > 80, LIN < 0.65, ALH > 6.5
o Linear= STR > 0.9, LIN > 0.5
o Non-linear= STR < 0.9, LIN < 0.5
o Curvilinear= DAP/radius ≥ 3 & LIN < 0.5
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APPENDIX B
FLOW CYTOMETRIC GATING
Appendix B.1 An example of flow cytometric analysis (CFlowPlus Software , Accuri Cytometer,
Ann Arbor, MI). The distribution of recorded events based on side-scatter and forward-scatter
characteristics is shown, with the population R1 (red) being the location of spermatozoa.
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Appendix B.2 Scatter dot plot of a viability stained equine semen sample analyzed with a flow
cytometer (CFlowPlus Software , Accuri Cytometer, Ann Arbor, MI). Axis are described as FL3-A
for red fluorescence and FL1-A for green fluorescence. R2, non-viable cells; R3, viable cells.

R2

R3
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APPENDIX B.3 Scatter plot of an acrosome integrity stained equine semen sample analyzed
with a flow cytometer. Quadratic gating was used to analyze the cell population (CFlowPlus
Software, Accuri Cytometer, Ann Arbor, MI). Upper left (UL), dead-nonreacted acrosome; upper
right (UR), dead-reacted acrosome; lower left (LL), viable-nonreacted acrosome; lower right
(LR), viable-reacted acrosome.

UL

UR

LL

LR
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APPENDIX C
EVENTS AND TRIALS USED FOR BINOMIAL LOGISTIC REGRESSION
Appendix C.1 The total events and trials used for the binomial logistic regression for total
motility pre-cryopreservation.
0% Iodixanol

2.50% Iodixanol

5% Iodixanol

Events

4695

4342

4096

Trials

7263

6792

6466

Appendix C.2 The total events and trials used for the binomial logistic regression for
progressive motility pre-cryopreservation.
0% Iodixanol

2.50% Iodixanol

5% Iodixanol

Events

3594

3594

3375

Trials

7263

6792

6466

Appendix C.3 The total events and trials used for the binomial logistic regression for total
motility at 5 and 30 mins post-thaw.

5 min Postthaw
30 min Postthaw

0% Iodixanol

2.50% Iodixanol

5% Iodixanol

Events

1900

1742

1913

Trials

5911

6160

6256

Events

1648

1464

1614

Trials

5911

6160

6256
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Appendix C.4 The total events and trials used for the binomial logistic regression for
progressive motility at 5 and 30 mins post-thaw.

5 min Postthaw
30 min Postthaw

0% Iodixanol

2.50% Iodixanol

5% Iodixanol

Events

1453

1287

1425

Trials

5911

6160

6256

Events

1208

1045

1183

Trials

5911

6160

6256

Appendix C.5 The total events and trials used for the binomial logistic regression for
spermatozoal viability pre-cryopreservation and post-thaw.

Precryopreservation

Post-thaw

0% Iodixanol

2.50% Iodixanol

5% Iodixanol

Viable

209410

209078

233270

Non-viable

139426

141610

137165

Trials

348836

350688

370435

Viable

69698

71336

70203

Non-viable

203295

195152

188800

Trials

272973

266488

259003
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Appendix C.6 The total events and trials used for the binomial logistic regression for
spermatozoal acrosomal integrity pre- and post-cryopreservation.

Precryopreservation

Non-viable &
intact acrosome
Non-viable &
non-viable
acrosome
Trials

Post-thaw

Non-viable &
intact acrosome
Non-viable &
non-viable
acrosome
Trials

0% Iodixanol

2.50% Iodixanol

5% Iodixanol

90247

91710

85410

48119

43778

42076

501467

499313

499795

121910

115944

111210

72558

75916

79260

540939

540652

540910

Appendix C.7 The total events and trials used for the binomial logistic regression of COMP αt.

Precryopreservation

0% Iodixanol

2.50% Iodixanol

5% Iodixanol

Events

12736

10300

11573

Trials

77174

76522

78159

Events

13057

11729

10724

Trials

76778

76790

76774

Post-thaw
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